This inventor holds 1 USPTO granted patent. Top assignee: Parker Hughes Institute. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: **Zhao-Hai Zhu: Innovator in Antiviral Pharmaceuticals**
Introduction
Zhao-Hai Zhu, located in Shoreview, Minnesota, is an accomplished inventor recognized for his contributions to antiviral drug development. His groundbreaking work focuses on enhancing the efficacy and longevity of key antiviral metabolites, showcasing his innovative approach in the pharmaceutical field.
Latest Patents
Zhao-Hai Zhu holds a significant patent titled "Aryl phosphate derivatives of d4T with potent anti-viral activity." This patent describes methods for increasing the elimination half-life of critical metabolites, such as d4T, by administering an aryl phosphate derivative that features both an electron-withdrawing substituent on the aryl group and an amino acid substituent on the phosphate group. One of his notable inventions, the HI-113 (d4T-5′-[p-bromophenyl methoxyalaninyl phosphate]), demonstrates improved systemic exposure to key metabolites, including Ala-d4T-MP and d4T, ensuring a more effective antiviral treatment.
Career Highlights
Zhao-Hai Zhu's career is marked by his affiliation with the Parker Hughes Institute, where he continues to make strides in the realm of antiviral research. His focus on innovative pharmaceutical compounds highlights a commitment to improving health outcomes through scientific advancements. His work not only contributes to understanding antiviral mechanisms but also addresses the challenges of drug delivery and metabolite stability.
Collaborations
Throughout his career, Zhao-Hai Zhu has collaborated with esteemed colleagues, including Fatih M. Uckun and Chun-Lin Chen. These partnerships enrich his research endeavors and amplify the impact of his findings in the medical and scientific communities.
Conclusion
Zhao-Hai Zhu exemplifies the spirit of innovation within the pharmaceutical industry. With a robust patent portfolio and a dedication to advancing antiviral therapies, he continues to pave the way for future breakthroughs. His work at the Parker Hughes Institute and collaborations with fellow researchers signify a bright future for antiviral drug development, highlighting the vital contributions of inventors like him in the ongoing battle against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile